Home / Import refusals / SCS-5764895-4/10002/1

FDA Import Refusal SCS-5764895-4/10002/1 — Janssen Inc.

Janssen Inc. — FEI 3002594622

The FDA refused shipment SCS-5764895-4/10002/1 from Janssen Inc. (Canada) on May 8, 2026. The refused product falls under Drugs and Biologics — RIVAROXABAN. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 8, 2026
Country
Canada
Product Category
Drugs and Biologics
Product Code
61LDY42 RIVAROXABAN
Charges
75

Other import refusals

  • 799-9144790-7/10003/1 (Fri Dec 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9144790-7/30003/1 (Fri Dec 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9144790-7/20003/1 (Fri Dec 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7355681-6/10003/1 (Fri Nov 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-9193140-4/13/1 (Thu Sep 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources